iSpecimen gets Nasdaq extension to meet $2.5 million stockholders’ equity rule by Nov. 25

• iSpecimen received a Nasdaq notice granting an extension to regain compliance with Listing Rule 5550(b) on minimum stockholders’ equity.
• Nasdaq first flagged the deficiency on May 29, 2026; the rule requires $2.5 million equity, $35 million market value, or $500,000 net income.
• Deadline to evidence compliance is Nov. 25, 2026; failure could trigger delisting proceedings, though trading continues for now.
• Compliance plan cites a May 11 private placement raising about $2.5 million, with a planned best-efforts public offering targeting about $5 million.
• Nasdaq will keep monitoring; the next annual filing for year ended Dec. 31, 2026 must also show compliance to avoid delisting risk.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iSpecimen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-098847), on September 10, 2026, and is solely responsible for the information contained therein.